Actively Recruiting
UKK-0018 as an Immunotherapeutic for Treatment of Peanut Allergies
Led by Ukko Inc · Updated on 2026-04-09
40
Participants Needed
5
Research Sites
88 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study will test a new investigational treatment called UKK-0018. UKK-0018 as an immunotherapeutic for the treatment of peanut allergies. The treatment is given by injection and is designed to train the immune system to tolerate peanut exposure over time.
CONDITIONS
Official Title
UKK-0018 as an Immunotherapeutic for Treatment of Peanut Allergies
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults 18-55 years old
- Documented history of physician-diagnosed peanut allergy
- Positive skin prick test (SPT) for peanut
- Screening double-blind placebo-controlled food challenge (DBPCFC) with peanut protein
- Use of contraception consistent with local regulations
- Ability to provide signed written informed consent
You will not qualify if you...
- Asthma based on NHLBI guidelines
- Uncontrolled cardiovascular disease
- History of chronic disease
- Exacerbation of dermatological conditions
- Life-threatening episodes of anaphylaxis
- Active infections
- Poor physical health or abnormal blood chemistry
- Immunodeficiency, bleeding disorders, or malignancies
- Hypersensitivity to epinephrine or inactive ingredients in the therapy
- Pregnant or breastfeeding
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 5 locations
1
Royal Prince Alfred Hospital
Camperdown, New South Wales, Australia, 2050
Not Yet Recruiting
2
Flinders Medical Center
Bedford Park, South Australia, Australia, 5042
Not Yet Recruiting
3
The Royal Melbourne Hospital
Fitzroy, Victoria, Australia, 3065
Not Yet Recruiting
4
Fiona Stanley Hospital
Perth, Western Australia, Australia, 6150
Not Yet Recruiting
5
Pacific Clinical Research Network - Auckland
Takapuna, Auckland, New Zealand, 0622
Actively Recruiting
Research Team
C
Clinical Development Officer
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here